Abstract
Behçet hastalığı olarak bilinen Behçet Sendromu, tekrarlayan oral aftlar ile beraber genital aft, oküler hastalık,gastrointestinal tutulum, nörolojik tutulum, vasküler hastalık veya artrit gibi sistemik belirtilerden herhangi biri ile karakterizedir. Sarkoidoz dünyada genelinde görülen tuttuğu organlarda non -kazeife granülomlar ile karakterize olan etyoloji net olarak bilinmeyen granülomatöz bir hastalıktır. BS ve sarkoidozun klinik seyrinde üveit, poliartrit, menenjit, kardiyovasküler hastalık, göğüs radyografilerinde anormallik izlendiğinden her iki hastalık birbirleri ile karıştırılabilir.
Keywords
Supporting Institution
YOK
Project Number
YOK
References
- Referans1 GulenHatemi, Peter A. Merkel, Vedat Hamuryudan, MaartenBoers, Haner Direskeneli, Sibel Z. Aydin, Hasan Yazici. OutcomeMeasuresUsed in ClinicalTrialsfor Behçet Syndrome: A SystematicReview J Rheumatol. Author manuscript; available in PMC 2015 Jul 20. 2014 Mar; 41(3): 599–612.
- Referans2 Sandro F. Perazzio, Luis E. C. Andrade, Alexandre W. S. de Souza. Understanding Behçet’s Disease in the Context of Innate Immunity Activation Front Immunol. 2020; 11: 586558.
- Referans3 Pleiades T. Inaoka, Masato Shono, Mishio Kamada, J. Luis Espinoza. Host-microbe interactions in the pathogenesis and clinical course of sarcoidosis J Biomed Sci. 2019; 26: 45.
- Referans4 Thomas W. McNally, Erika M. Damato, Philip I. Murray, Alastair K. Denniston, Robert J. BarryOrphanet J. An update on the use of biologic therapies in the management of uveitis in Behçet’s disease: a comprehensive review Rare Dis. 2017; 12: 130.
- Referans5 Julie Gueudry, Mathilde Leclercq, David Saadoun, Bahram Bodaghi. Old and New Challenges in Uveitis Associated with Behçet’s Disease J Clin Med. 2021 Jun; 10(11): 2318.
- Referans6 Sarcoidosis Robicheaux Clementine, Rochelle MD*; Lyman, Justin MD*; Zakem, Jerald MD*; Mallepalli, Jyothi MD†; Lindsey, Stephen MD*; Quinet, Robert MD* . Tumor Necrosis Factor-Alpha Antagonist-Induced JCR: Journal of Clinical Rheumatology: September 2010 - Volume 16 - Issue 6 - p 274-279.
Abstract
Behçet syndrome(BS), also known as Behçet disease (BD), is characterized by recurrent oral aphthae and any of several systemic manifestations including genital aphthae, ocular disease, skin lesions, gastrointestinal involvement, neurologic disease, vascular disease or arthritis. Sarcoidosis is a multisystem granulomatous disorder of unknown etiology that affects individuals worldwide and is characterized pathologically by the presence of noncaseating granulomas in involved organs. BD may be confused with sarcoidosis because they are both multisystem inflammatory disorders presenting with uveitis, polyarthritis, meningitis, cardiovascular disease, erythema nodosum, and other cutaneous lesions, and abnormal chest radiographs.
Keywords
Project Number
YOK
References
- Referans1 GulenHatemi, Peter A. Merkel, Vedat Hamuryudan, MaartenBoers, Haner Direskeneli, Sibel Z. Aydin, Hasan Yazici. OutcomeMeasuresUsed in ClinicalTrialsfor Behçet Syndrome: A SystematicReview J Rheumatol. Author manuscript; available in PMC 2015 Jul 20. 2014 Mar; 41(3): 599–612.
- Referans2 Sandro F. Perazzio, Luis E. C. Andrade, Alexandre W. S. de Souza. Understanding Behçet’s Disease in the Context of Innate Immunity Activation Front Immunol. 2020; 11: 586558.
- Referans3 Pleiades T. Inaoka, Masato Shono, Mishio Kamada, J. Luis Espinoza. Host-microbe interactions in the pathogenesis and clinical course of sarcoidosis J Biomed Sci. 2019; 26: 45.
- Referans4 Thomas W. McNally, Erika M. Damato, Philip I. Murray, Alastair K. Denniston, Robert J. BarryOrphanet J. An update on the use of biologic therapies in the management of uveitis in Behçet’s disease: a comprehensive review Rare Dis. 2017; 12: 130.
- Referans5 Julie Gueudry, Mathilde Leclercq, David Saadoun, Bahram Bodaghi. Old and New Challenges in Uveitis Associated with Behçet’s Disease J Clin Med. 2021 Jun; 10(11): 2318.
- Referans6 Sarcoidosis Robicheaux Clementine, Rochelle MD*; Lyman, Justin MD*; Zakem, Jerald MD*; Mallepalli, Jyothi MD†; Lindsey, Stephen MD*; Quinet, Robert MD* . Tumor Necrosis Factor-Alpha Antagonist-Induced JCR: Journal of Clinical Rheumatology: September 2010 - Volume 16 - Issue 6 - p 274-279.
Details
| Primary Language | English |
|---|---|
| Subjects | Clinical Sciences |
| Journal Section | Letter to the Editor |
| Authors | |
| Project Number | YOK |
| Publication Date | December 28, 2022 |
| Acceptance Date | November 2, 2022 |
| Published in Issue | Year 2022 Volume: 47 Issue: 4 |
